F. G. Feturi Et Al. , "Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity," PHARMACEUTICAL RESEARCH , vol.39, no.9, pp.2179-2190, 2022
Feturi, F. G. Et Al. 2022. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity. PHARMACEUTICAL RESEARCH , vol.39, no.9 , 2179-2190.
Feturi, F. G., Unadkat, J., Zhang, W., El Hag, M., Wang, Y., Komatsu, C., ... Grybowski, D.(2022). Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity. PHARMACEUTICAL RESEARCH , vol.39, no.9, 2179-2190.
Feturi, Firuz Et Al. "Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity," PHARMACEUTICAL RESEARCH , vol.39, no.9, 2179-2190, 2022
Feturi, Firuz G. Et Al. "Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity." PHARMACEUTICAL RESEARCH , vol.39, no.9, pp.2179-2190, 2022
Feturi, F. G. Et Al. (2022) . "Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity." PHARMACEUTICAL RESEARCH , vol.39, no.9, pp.2179-2190.
@article{article, author={Firuz G. Feturi Et Al. }, title={Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity}, journal={PHARMACEUTICAL RESEARCH}, year=2022, pages={2179-2190} }